CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 48,225 shares at $2.04 ($98,572)
- 4 Open-market buy Director bought 10,000 shares at $2.08 ($20,825)
- 4 Open-market buy Director bought 150,000 shares at $2.78 ($416,250)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 38,263 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 18,263 shares (to pay taxes)
- 4 Grant or award Chief Commercial Officer acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 100,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at $3.33 ($83,278)
- 4 Grant or award Chief Medical Officer acquired 80,000 shares (grant or award)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 54,702 shares at $3.31 ($180,828)
- 4 Open-market sale Director sold 8,000 shares at $3.32 ($26,569)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Open-market buy Director bought 20,000 shares at $2.95 ($59,072)
- 4 Open-market buy Director bought 100,000 shares at $2.88 ($287,600)
Page 2 of 22 · 436 filings